SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:lup.lub.lu.se:e5c1b5a7-e0e0-4463-87c8-bbc2439dfa19"
 

Sökning: onr:"swepub:oai:lup.lub.lu.se:e5c1b5a7-e0e0-4463-87c8-bbc2439dfa19" > Global cancer surge...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005502naa a2200805 4500
001oai:lup.lub.lu.se:e5c1b5a7-e0e0-4463-87c8-bbc2439dfa19
003SwePub
008160401s2015 | |||||||||||000 ||eng|
0247 a https://lup.lub.lu.se/record/80709342 URI
0247 a https://doi.org/10.1016/S1470-2045(15)00223-52 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
1001 a Sullivan, Richard4 aut
2451 0a Global cancer surgery: delivering safe, affordable, and timely cancer surgery
264 1c 2015
520 a Surgery is essential for global cancer care in all resource settings. Of the 15.2 million new cases of cancer in 2015, over 80% of cases will need surgery, some several times. By 2030, we estimate that annually 45 million surgical procedures will be needed worldwide. Yet, less than 25% of patients with cancer worldwide actually get safe, aff ordable, or timely surgery. This Commission on global cancer surgery, building on Global Surgery 2030, has examined the state of global cancer surgery through an analysis of the burden of surgical disease and breadth of cancer surgery, economics and fi nancing, factors for strengthening surgical systems for cancer with multiple-country studies, the research agenda, and the political factors that frame policy making in this area. We found wide equity and economic gaps in global cancer surgery. Many patients throughout the world do not have access to cancer surgery, and the failure to train more cancer surgeons and strengthen systems could result in as much as US$ 6.2 trillion in lost cumulative gross domestic product by 2030. Many of the key adjunct treatment modalities for cancer surgery-eg, pathology and imaging-are also inadequate. Our analysis identifi ed substantial issues, but also highlights solutions and innovations. Issues of access, a paucity of investment in public surgical systems, low investment in research, and training and education gaps are remarkably widespread. Solutions include better regulated public systems, international partnerships, super-centralisation of surgical services, novel surgical clinical trials, and new approaches to improve quality and scale up cancer surgical systems through education and training. Our key messages are directed at many global stakeholders, but the central message is that to deliver safe, aff ordable, and timely cancer surgery to all, surgery must be at the heart of global and national cancer control planning.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kirurgi0 (SwePub)302122 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Surgery0 (SwePub)302122 hsv//eng
7001 a Alatise, Olusegun Isaac4 aut
7001 a Anderson, Benjamin O.4 aut
7001 a Audisio, Riccardo4 aut
7001 a Autier, Philippe4 aut
7001 a Aggarwal, Ajay4 aut
7001 a Balch, Charles4 aut
7001 a Brennan, Murray F.4 aut
7001 a Dare, Anna4 aut
7001 a D'Cruz, Anil4 aut
7001 a Eggermont, Alexander M. M.4 aut
7001 a Fleming, Kenneth4 aut
7001 a Gueye, Serigne Magueye4 aut
7001 a Hagander, Larsu Lund University,Lunds universitet,Pediatrik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Kirurgi och folkhälsa,Forskargrupper vid Lunds universitet,Paediatrics (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Surgery and public health,Lund University Research Groups4 aut0 (Swepub:lu)med-lhd
7001 a Herrera, Cristian A.4 aut
7001 a Holmer, Hampusu Lund University,Lunds universitet,Pediatrik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Paediatrics (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)med-hsh
7001 a Ilbawi, Andre4 aut
7001 a Jarnheimer, Anton4 aut
7001 a Ji, Jia-fu4 aut
7001 a Kingham, T. Peter4 aut
7001 a Liberman, Jonathan4 aut
7001 a Leather, Andrew J. M.4 aut
7001 a Meara, John G.4 aut
7001 a Mukhopadhyay, Swagoto4 aut
7001 a Murthy, Shilpa S.4 aut
7001 a Omar, Sherif4 aut
7001 a Parham, Groesbeck P.4 aut
7001 a Pramesh, C. S.4 aut
7001 a Riviello, Robert4 aut
7001 a Rodin, Danielle4 aut
7001 a Santini, Luiz4 aut
7001 a Shrikhande, Shailesh V.4 aut
7001 a Shrime, Mark4 aut
7001 a Thomas, Robert4 aut
7001 a Tsunoda, Audrey T.4 aut
7001 a van de Velde, Cornelis4 aut
7001 a Veronesi, Umberto4 aut
7001 a Vijaykumar, Dehannathparambil Kottarathil4 aut
7001 a Watters, David4 aut
7001 a Wang, Shan4 aut
7001 a Wu, Yi-Long4 aut
7001 a Zeiton, Moez4 aut
7001 a Purushotham, Arnie4 aut
7102 a Pediatrik, Lundb Sektion V4 org
7730 t The Lancet Oncologyg 16:11, s. 1193-1224q 16:11<1193-1224x 1474-5488
8564 u http://dx.doi.org/10.1016/S1470-2045(15)00223-5y FULLTEXT
8564 8u https://lup.lub.lu.se/record/8070934
8564 8u https://doi.org/10.1016/S1470-2045(15)00223-5

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy